10x Genomics, Inc. TXG Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s return on assets?
- 10x Genomics, Inc. (TXG) reported return on assets of -2.4% in Q1 2026.
- How has 10x Genomics, Inc.'s return on assets changed year-over-year?
- 10x Genomics, Inc.'s return on assets increased by 86.3% year-over-year, from -17.2% to -2.4%.
- What is the long-term trend for 10x Genomics, Inc.'s return on assets?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s return on assets has grown at a -42.5% compound annual growth rate (CAGR), from -70.7% to -4.4%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.